GS Investments’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,333
| Closed | -$270K | – | 154 |
|
|
2021
Q4 | $270K | Hold |
1,333
| – | – | 0.13% | 83 |
|
|
2021
Q3 | $359K | Buy |
+1,333
| New | +$359K | 0.19% | 76 |
|
|
2021
Q1 | – | Sell |
-1,260
| Closed | -$321K | – | 101 |
|
|
2020
Q4 | $321K | Buy |
+1,260
| New | +$321K | 0.31% | 66 |
|
|
2020
Q3 | – | Sell |
-3,613
| Closed | -$1.26M | – | 90 |
|
|
2020
Q2 | $1.26M | Hold |
3,613
| – | – | 1% | 32 |
|
|
2020
Q1 | $967K | Buy |
3,613
+20
| +0.6% | +$5.36K | 0.95% | 34 |
|
|
2019
Q4 | $2.63M | Sell |
3,593
-20
| -0.6% | -$14.7K | 2.18% | 13 |
|
|
2019
Q3 | $987K | Hold |
3,613
| – | – | 0.72% | 42 |
|
|
2019
Q2 | $1.93M | Hold |
3,613
| – | – | 1.58% | 26 |
|
|
2019
Q1 | $1.82M | Buy |
3,613
+13
| +0.4% | +$6.55K | 1.43% | 30 |
|
|
2018
Q4 | $1.77M | Hold |
3,600
| – | – | 1.49% | 26 |
|
|
2018
Q3 | $3.29M | Hold |
3,600
| – | – | 2.3% | 10 |
|
|
2018
Q2 | $2.64M | Buy |
3,600
+133
| +4% | +$97.4K | 1.97% | 15 |
|
|
2018
Q1 | $5.53M | Sell |
3,467
-317
| -8% | -$505K | 4.05% | 4 |
|
|
2017
Q4 | $3.39M | Sell |
3,784
-3
| -0.1% | -$2.69K | 2.59% | 9 |
|
|
2017
Q3 | $1.36M | Buy |
3,787
+356
| +10% | +$128K | 1.09% | 36 |
|
|
2017
Q2 | $1.01M | Buy |
+3,431
| New | +$1.01M | 0.75% | 40 |
|